Abstract

The COVID-19 pandemic has brought into focus the complexity and interrelatedness of the range of health care delivery associated with translational cancer research. Importantly it highlights the potential fragility and also strengths of this ecosystem.

Rights

This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.

Cite as

Keith, N., Plummer, R., Coyle, V., Cameron, D., Evans, J., Twelves, C., Palmer, D., Danson, S., Graham, D. & Welisch, G. 2021, Early Phase Cancer Research in the COVID-19 Pandemic: an ECMC North Initiative, OSF. Available at: https://doi.org/10.17605/OSF.IO/6WTN2

Downloadable citations

Download HTML citationHTML Download BIB citationBIB Download RIS citationRIS
Last updated: 17 June 2022
Was this page helpful?